522 Quantitative proteomic profiling of KZR-540, a novel small molecule oral Sec61 inhibitor that selectively inhibits PD-1 expression

• Christopher Kirk,
• Yu Qian,
• Jinhai Wang,
• Patricia Zuno-Mitchell,
• David L Bade,
• Neel K Anand,
• Cristina Delgado Martin,
• Vaishnavi Beena Valsan

Affiliations

Christopher Kirk

Kezar Life Sciences, South San Francisco, CA, USA

Yu Qian

Kezar Life Sciences, South San Francisco, CA, USA

Jinhai Wang

Kezar Life Sciences, South San Francisco, CA, USA

Patricia Zuno-Mitchell

Kezar Life Sciences, South San Francisco, CA, USA

David L Bade

Kezar Life Sciences, South San Francisco, CA, USA

Neel K Anand

Kezar Life Sciences, South San Francisco, CA, USA

Cristina Delgado Martin

Kezar Life Sciences, South San Francisco, CA, USA

Vaishnavi Beena Valsan

Kezar Life Sciences, South San Francisco, CA, USA